(DKKm) | Group | |||
27. Fair value disclosure – continued | ||||
2022 | Listed prices | Observable input | Non-observable input | Total |
Fair value, Group | ||||
Financial assets at fair value broken down into: | ||||
Bonds | 9,333 | 912 | 3 | 10,248 |
Shares, etc. | 0 | 0 | 10 | 10 |
Investment properties | 0 | 12 | 0 | 12 |
Total | 9,333 | 924 | 13 | 10,270 |
2021 | Listed prices | Observable input | Non-observable input | Total |
Fair value, Group | ||||
Financial assets at fair value broken down into: | ||||
Bonds | 11,610 | 0 | 5 | 11,615 |
Shares, etc. | 0 | 3 | 9 | 12 |
Investment properties | 0 | 10 | 0 | 10 |
Total | 11,610 | 13 | 14 | 11,637 |
Fair value based on non-observable input | 2022 | 2021 |
Beginning of year | 14 | 24 |
Value adjustment through the income statement (note 7) | -1 | 10 |
Disposals during the year (including reclassification) | 0 | -20 |
Fair value, end of year | 13 | 14 |
(DKKm) | Group | |||
28. Fair value of balance sheet items at amortised cost | ||||
The vast majority of the Group’s receivables, loans and deposits cannot be transferred without the customer’s prior acceptance, and no active market exists for trading in such financial instruments. Estimated fair values are based on situations where changes in market conditions have been identified after initial recognition of the instrument, affecting the price that would have been agreed if the terms had been agreed at the balance sheet date. As a result, the fair values below are subject to considerable uncertainty. | ||||
2022 | 2021 | |||
Amortised cost | Fair value | Amortised cost | Fair value | |
Financial assets | ||||
Cash in hand and demand deposits with central banks | 9,911 | 9,911 | 8,149 | 8,149 |
Due from credit institutions and central banks | 5 | 5 | 13 | 13 |
Loans, advances and other receivables* | 33 | 33 | 91 | 91 |
Commitments made by banks, mortgage credit institutions and investment companies | 3,218 | 3,218 | 3,217 | 3,217 |
Total financial assets | 13,167 | 13,167 | 11,470 | 11,470 |
*) Loans, advances and other receivables are considered to be stage 3 exposures, see note 11, and thus to be credit-impaired. Against this background, amortised cost and fair value are considered to be identical. |
29. Return on financial instruments | ||||||
2022 | 2021 | |||||
Assets/ liabilities at amortised cost | Assets/ liabilities at fair value | Total | Assets/ liabilities at amortised cost | Assets/ liabilities at fair value | Total | |
Interest income | 3 | 114 | 117 | 7 | 113 | 120 |
Interest expense | 0 | 0 | 0 | 34 | 0 | 34 |
Net interest income | 3 | 114 | 117 | -27 | 113 | 86 |
Share dividends, etc. | 0 | 0 | 0 | 0 | 1 | 1 |
Fees and commissions received | 2 | 0 | 2 | 2 | 0 | 2 |
Net interest and fee income | 5 | 114 | 119 | -25 | 114 | 89 |
Market value adjustments | 0 | -859 | -859 | 0 | -182 | -182 |
Total | 5 | -745 | -740 | -25 | -68 | -93 |